BNT162b2 booster dose associated with reduced risk of SARS-CoV-2 infection and mortality among older adults in long-term care facilities
1. This observational cohort study demonstrated that among long-term care residents in Israel, the BNT162b2 (Pfizer-BioNTech) booster dose (third overall ...